Bone scan for baseline staging in invasive breast cancer at the time of primary presentation

Breast Care

Volumn 2, Issue 6, 2007, Pages 358-364

  Puglisi, Fabio ^a   Andreetta, Claudia ^a   Fasola, Gianpiero ^a   Cattaruzzi, Elena ^a   Geatti, Onelio ^a  

^a UNIVERSITY HOSPITAL OF UDINE   (Italy)

Author keywords

Bone scan; Breast cancer; Staging

Indexed keywords

MEDRONATE TECHNETIUM TC 99M;

BONE METASTASIS; BONE SCINTISCANNING; BREAST CANCER; CANCER DIAGNOSIS; CANCER STAGING; CLINICAL PRACTICE; COMPUTER ASSISTED TOMOGRAPHY; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; WHOLE BODY SCINTISCANNING;

EID: 38549143303     PISSN: 16613791     EISSN: 16613805     Source Type: Journal    
DOI: 10.1159/000111546     Document Type: Review

References (56)

1. Scanlon EF, Oviedo MA, Cunningham MP, Caprini JA, Khandekar JD, Cohen E, Robinson B, Stein E: Preoperative and follow-up procedures on patients with breast cancer. Cancer 1980;46:977-979.
2. Feig SA: The role of new imaging modalities in staging and follow-up of breast cancer. Semin Oncol 1986;13:402-414.
3. Morrow M: What is the purpose of cancer staging? Breast 2006;15:1-2.
4. Ciatto S, Pacini P, Azzini V, Neri A, Jannini A, Gosso P, Molino A, Capelli A, Di Costanzo F, Pucciatti MA, Andreoli C, Santoro G, Farante G, Ciurli M, Costa A, Brignone G, Ravaioli A, Scarpellini M, Rosetti P, De Leo G, Punzo C, Oliva V: Preoperative staging of primary breast cancer: a multicenter study. Cancer 1988;61:1038-1040.
5. Samant R, Ganguly P: Staging investigations in patients with breast cancer: the role of bone scans and liver imaging. Arch Surg 1999;134:551-553.
6. Chen A, Carlson GA, Coughlin BF, Reed WP, Garb JL, Frank JL: Routine chest roentgenography is unnecessary in the work-up of stage I and II breast cancer. J Clin Oncol 2000;18:3503-3506.
7. Dillman RO, Chico S: Radiologic tests after a new diagnosis of breast cancer. Eff Clin Pract 2000;3:1-6.
8. Curigliano G, Ferretti G, Colleoni M, Marrocco E, Peruzzotti G, De Cicco C, Paganelli G, Goldhirsch A: Bone scan had no role in the staging of 765 consecutive operable T1-2N 0-1 breast cancer patients without skeletal symptoms. Ann Oncol 2001;12:724-725.
9. Myers RE, Johnston M, Pritchard K, Levine M, Oliver T and the Breast Cancer Disease Site Group of the Cancer Care Ontario Practice Guidelines Initiative: Baseline staging tests in primary breast cancer: a practice guideline. CMAJ 2001;164:1439-1444.
10. Ravaioli A, Pasini G, Polselli A, Papi M, Tassinari D, Arcangeli V, Milandri C, Amadori D, Bravi M, Rossi D, Fattori PP, Pasquini E, Panzini I: Staging of breast cancer: new recommended standard procedure. Breast Cancer Res Treat 2002;72:53-60.
11. Gerber B, Seitz E, Muller H, Krause A, Reimer T, Kundt G, Friese K: Perioperative screening for metastatic disease is not indicated in patients with primary breast cancer and no clinical signs of tumor spread. Breast Cancer Res Treat 2003;82:29-37.
12. Schneider C, Fehr MK, Steiner RA, Hagen D, Haller U: Frequency and distribution pattern of distant metastases in breast cancer patients at the time of primary presentation. Arch Gynecol Obstet 2003;269:9-12.
13. Puglisi F, Follador A, Minisini AM, Cardellino GG, Russo S, Andreetta C, Di Terlizzi S, Piga A: Baseline staging tests after a new diagnosis of breast cancer: further evidence of their limited indications. Ann Oncol 2005;16:263-266.
14. Lee JE, Park SS, Han W, Kim SW, Shin HJ, Choe KJ, Oh SK, Youn YK, Noh DY, Kim SW: The clinical use of staging bone scan in patients with breast carcinoma: reevaluation by the 2003 American Joint Committee on Cancer staging system. Cancer 2005;104:499-503.
15. Coleman RE, Rubens RD: The clinical course of bone metastases from breast cancer. Br J Cancer 1987;55:61-66.
16. Roodman GD: Mechanisms of bone metastasis. N Engl J Med 2004;350:1655-1664.
17. Mundy G: Metastatic bone disease; in Fogelman I (ed): Bone Remodelling and Its Disorders. London, Martin Dunitz,1995, pp. 104-122.
18. Hamaoka T, Madewell JE, Podoloff DA, Hortobagyi GN, Ueno NT: Bone imaging in metastatic breast cancer. J Clin Oncol 2004;22:2942-2953.
19. Morgan-Pakes JH: Metastases: mechanism, pathways, and cases. AJR 1995;164:1075-1082.
20. Krasnow AZ, Hellman RS, Timins ME, Collier BD, Anderson T, Isitman AT: Diagnostic bone scanning in oncology. Sem Nucl Med 1997;27:107-141.
21. O'Sullivan JM, Cook GJR: A review of the efficacy of bone scanning in prostate and breast cancer. Q J Nucl Med 2002;46:152-159.
22. Cook GJ, Fogelman I: Skeletal metastases from breast cancer: imaging with nuclear medicine. Semin Nucl Med 1999;29:69-79.
23. Buscombe JR, Holloway B, Roche N, Bombardieri E: Position of nuclear medicine modalities in the diagnostic work-up of breast cancer. Q J Nucl Med Mol Imaging 2004;48:109-118.
24. Haubold-Reuter BG, Duewell S, Schilcher BR, Marincek B, von Schulthess GK: The value of bone scintigraphy, bone marrow scintigraphy and fast spin-echo magnetic resonance imaging in staging of patients with malignant solid tumours: a prospective study- Eur J Nucl Med 1993;20:1063-1069.
25. Demirkan B, Baskan Z, Alacacioglu A, Gorken IB, Bekis R, Ada E, Osma E, Alakavuklar M: False negative bone scintigraphy in a patient with primary breast cancer: a possible transient phenomenon of bisphosphonate (alendronate) treatment. Tumori 2005;91:77-80.
26. Byrne AM, Hill ADK, Skehan SJ, McDermott EW, O'Higgins NJ: Positron emission tomography in the staging and management of breast cancer. Br J Surg 2004;91:1398-1409.
27. Gosfield E, III, Alavi A, Kneeland B: Comparison of radionuclide bone scans and magnetic resonance imaging in detecting spinal metastases. J Nucl Med 1993;34:2191-2198.
28. Crippa F, Seregni E, Agresti R, Bombardieri E, Buraggi GL: Bone scintigraphy in breast cancer: a ten-year follow-up study. J Nucl Biol Med 1993;37:57-61.
29. Klaeser B, Wiederkehr O, Koeberle D, Mueller A, Bubeck B, Thuerlimann B: Therapeutic impact of 2-[fluorine-18]fluoro-2-deoxy-D-glucose positron emission tomography in the pre- and postoperative staging of patients with clinically intermediate or high-risk breast cancer. Ann Oncol 2007;18:1329-1334.
30. Langsteger W, Heinisch M, Fogelman I: The role of fluorodeoxyglucose, 18F-dihydroxyphenylalanine, 18F-choline, and 18F-fluoride in bone imaging with emphasis on prostate and breast. Sem Nucl Med 2006;36:73-92.
31. Horger M, Bares R: The role of single-photon emission computed tomography/computed tomography in benign and malignant bone disease. Semin Nucl Med 2006;36:286-294.
32. Galasko CSB: The detection of skeletal metastases for mammary cancer by gamma camera scintigraphy. Br J Surg 1969;56:757-764.
33. Gerber FH, Goodreau JJ, Kirchner PT, Fouty WJ: Efficacy of preoperative and postoperative bone scanning in the management of breast carcinoma. N Engl J Med 1977;297:300-303.
34. Lind DS: Breast cancer testing: what is appropriate? J Surg Oncol 2002;81:111-112.
35. Puglisi F: Bone scanning in lung cancer: pretest probability is of value. BMJ 2004;329:231.
36. Khatcheressian JL, Wolff AC, Smith TJ, Grunfeld E, Muss HB, Vogel VG, Halberg F, Somerfield MR, Davidson NE; American Society of Clinical Oncology: American Society of Clinical Oncology 2006 update of the breast cancer follow-up and management guidelines in the adjuvant setting. J Clin Oncol 2006;24:5091-5097.
37. NCCN Clinical Practice Guidelines in Oncology. Breast Cancer, version 2, 2007, www.nccn.org.
38. No authors listed: Primary breast cancer: ESMO Clinical Recommendations for diagnosis, treatment and follow-up. Ann Oncol 2007;18:ii5-ii8.
39. Tassinari D, Sartori S, Ravaioli A: Staging breast cancer. Is the evidence so evident? Ann Oncol 2001;12:1653-1654.
40. Ho YY, Chan YH: Predictors of a positive baseline bone scan in breast cancer. Australas Radiol 2005;49:21-26.
41. Rapiti E, Verkooijen HM, Vlastos G, Fioretta G, Neyroud-Caspar I, Sappino AP, Chappuis PO, Bouchardy C: Complete excision of primary breast tumor improves survival of patients with metastatic breast cancer at diagnosis. J Clin Oncol 2006;24:2743-2749.
42. Monypenny IJ, Grieve RJ, Howell A, Morrison JM: The value of serial bone scanning in operable breast cancer. Br J Surg 1984;71:466-468.
43. Kunkler IH, Merrick MV, Rodger A: Bone scintigraphy in breast cancer: a nine-year follow-up. Clin Radiol 1985;36:279-282.
44. Khansur T, Haick A, Patel B, Balducci L, Vance R, Thigpen T: Evaluation of bone scan as a screening wok-up in primary and local-regional recurrence of breast cancer. Am J Clin Oncol 1987;10:167-170.
45. Coleman RE, Rubens RD, Fogelman I: Reappraisal of the baseline bone scan in breast cancer. J Nucl Med 1988;29:1045-1049.
46. Piffer S, Amichetti M, Valentini A: Skeletal scintigraphy and physical examination in the staging of early breast cancer. Acta Oncologica 1988;27:21-23.
47. Ahmed A, Glynne-Jones R, Ell PJ: Skeletal scintigraphy in carcinoma of the breast - a ten year retrospective study of 389 patients. Nucl Med Commun 1990;11:421-426.
48. Kennedy H, Kennedy N, Barclay M, Horobin M: Cost efficiency of bone scans in breast cancer. Clin Oncol 1991;3:73-77.
49. Cox MR, Gilliland R, Odling-Smee GW, Spence RA: An evaluation of radionuclide bone scanning and liver ultrasonography for staging breast cancer. Aust N Z J Surg 1992;62:550-555.
50. Brar HS, Sisley JF, Johnson RH Jr: Value of preoperative bone and liver scans and alkaline phosphatase in the evaluation of breast cancer patients. Am J Surg 1993;165:221-224.
51. Alcazar JL, Rolle A, Murcia JM: Bone scanning in preoperative staging of early breast cancer patients: should it be a routine procedure? Breast Dis 1995;8:7-11.
52. Yeh KA, Fortunato L, Ridge JA, Hoffman JP, Eisenberg BL, Sigurdson ER: Routine bone scanning in patients with T1 and T2 breast cancer: a waste of money. Ann Surg Oncol 1995;2:319-324.
53. Miner TJ, Shriver CD, Jaques DP, Schutt DC: The department of Defense experience in perioperative testing for metastatic disease in patients with breast cancer. Breast J 1998;4:84-88.
54. Yip CH, Paramsothy M: Value of routine 99mTc-MDP bone scintigraphy in the detection of occult skeletal metastases in women with primary breast cancer. Breast 1999;8:267-269.
55. Koizumi M, Yoshimoto M, Kasumi F, Ogata E: What do breast cancer patients benefit from staging bone scintigraphy? Jpn J Clin Oncol 2001;31:263-269.
56. Kasem AR, Desai A, Daniell S, Sinha P: Bone scan and liver ultrasound scan in the preoperative staging for primary breast cancer. Breast J 2006;12:544-548.